logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Z

Zev A. Wainberg

Ronald Reagan UCLA Medical Center
H指数:71
被引数:2.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic cancer: the randomized phase 2 AMPLIFY-7P trial

淋巴结靶向、mKRAS特异性的两亲性疫苗在胰腺癌中的研究：AMPLIFY-7P随机II期试验

Nature Medicine
IF50
2026-10-230
OAAI
Ben George; Harshabad Singh; Craig E. Devoe; Vincent Chung; Peter J. Hosein; Andrew Hendifar; Dae Won Kim; Jennifer B. Valerin; Tanios Bekaii-Saab; Dana B. Cardin; Manuel Hidalgo; Pashtoon M. Kasi; Alexis D. Leal; Meredith Pelster; Naomi Fei; Colin D. Weekes; Mark H. O’Hara; Thomas J. George; Syed M. Kazmi; Jonathan D. Mizrahi; Suresh Nair; Martin Maiers; Thian Kheoh; Gianni Amato; Jino Xavier; Julia P. Snyder; Madison H. Milaszewski; Xavier Cabana-Puig; James R. Perry; Lisa K. McNeil; Esther Welkowsky; Peter C. DeMuth; Christopher M. Haqq; Shubham Pant; Zev A. Wainberg; Eileen M. O’Reilly
Evorpacept plus trastuzumab, ramucirumab and paclitaxel in HER2-positive gastric cancer: a randomized phase 2 trial

Evorpacept联合曲妥珠单抗、雷莫昔单抗和紫杉醇治疗HER2-positive胃癌: 一项随机2期试验

Nature Medicine
IF50
2026-09-240
OAAI
Kohei Shitara; Zev Wainberg; Josep Tabernero; Eric Van Cutsem; Clélia Coutzac; Christelle De La Fouchardière; Jeeyun Lee; Sun Young Rha; Yoon-Koo Kang; Philip Fanning; Alison Forgie; Cherry Mao; Daniel Brickman; Jaume Pons; Athanasios C. Tsiatis; Sophia Randolph; Keun-Wook Lee
Neoadjuvant stereotactic body vs conventionally fractionated radiation therapy for borderline resectable and locally advanced pancreatic cancer: a propensity score-matched analysis

新辅助立体定向体部放疗与常规分割放疗治疗 borderline resectable 和局部晚期胰腺癌：一项倾向性评分匹配分析

Journal of Gastrointestinal Surgery
IF2.4
2026-04-010
PRE
Shimizu, Takayuki; Zheng, Serena; Maeda, Shimpei; Link, Jason; Deranteriassian, Aletta; Premji, Alykhan; King, Johathan; Girgis, Mark; Hines, Oscar Joe; Wainberg, Zev; Raldow, Ann; He, Jin; Burns, William; Narang, Amol; Qadan, Motaz; Castillo, Carlos Fernandez-Del; Lillemoe, Keith D.; Wo, Jennifer; Hong, Theodore; Donahue, Timothy R.
Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trial

新辅助改良FOLFIRINOX联合nivolumab治疗可切除的胰腺导管腺癌: 一项1期试验

Nature Communications
IF15.7
2026-01-310
OA
Zev A. Wainberg; Jason M. Link; Alykhan Premji; Serena Zheng; Michael Srienc; McKensie Hammons; Shineui E. Kim; Luyi Li; Zeyu Liu; Olga Tsvetkova; Evan R. Abt; Lee Rosen; Stephen Kim; Jonathan King; O. Joe Hines; Mark Girgis; Saeed Sadeghi; Olga Olevsky; Deborah Wong; Lisa Yonemoto; Ann Marie Siney; Kim Kelly; Christine Kivork; Chi-Hong Tseng; Caius G. Radu; David W. Dawson; Timothy R. Donahue
First-line tiragolumab plus atezolizumab and chemotherapy in patients with previously untreated, locally advanced unresectable or metastatic oesophageal cancer (MORPHEUS-EC): a randomised, open-label, phase 1b/2 trial

一线tiragolumab联合atezolizumab和化疗治疗既往未治疗、局部晚期不可切除或转移性食管癌（MORPHEUS-EC）：一项随机、开放标签、1b/2期试验

The Lancet Oncology
IF0
2025-12-220
PRE
Jong-Mu Sun; Yee Chao; Sung-Bae Kim; Sun Young Rha; Thomas R Jeffry Evans; Andrew H Strickland; Zev Wainberg; Ian Chau; Sharon Pelles-Avraham; Jaffer Ajani; Ritu Malhotra; Qingyuan Liu; Sijing Li; Edward Cha; Melania Kalaitzidou; Xiayu Huang; Simon Allen; Chih-Hung Hsu
Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final results

淋巴结靶向、mKRAS特异性的两亲性疫苗在胰腺癌和结直肠癌中的研究：AMPLIFY-201试验1期最终结果

Nature Medicine
IF50
2025-08-110
OAAI
Zev A. Wainberg; Colin D. Weekes; Muhammad Furqan; Pashtoon M. Kasi; Craig E. Devoe; Alexis D. Leal; Vincent Chung; James R. Perry; Thian Kheoh; Lisa K. McNeil; Esther Welkowsky; Peter C. DeMuth; Christopher M. Haqq; Shubham Pant; Eileen M. O’Reilly
Health-related quality of life and performance status with NALIRIFOX versus nab-paclitaxel + gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma: results from the NAPOLI 3 trial

与健康相关的生活质量和体力状态：NALIRIFOX与nab-paclitaxel + gemcitabine在治疗初治的转移性胰腺导管腺癌患者中的比较：NAPOLI 3试验结果

ESMO Open
IF8.3
2025-08-050
OAAI
D. Melisi; T. Macarulla; C. De La Fouchardière; R.A. Pazo Cid; S.R. Chandana; I. Kiss; W.J. Lee; T.O. Goetze; E. Van Cutsem; A.S. Paulson; T. Bekaii-Saab; S. Pant; R.A. Hubner; F. Maxwell; L. Zhang; F. Benzaghou; E.M. O’Reilly; Z.A. Wainberg
Gastric Cancer, Version 2.2025

《胃癌》，版本2.2025

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
IF16.4
2025-05-010
PRE
Ajani, Jaffer A.; D'Amico, Thomas A.; Bentrem, David J.; Corvera, Carlos U.; Das, Prajnan; Enzinger, Peter C.; Enzler, Thomas; Gerdes, Hans; Gibson, Michael K.; Grierson, Patrick; Gupta, Garima; Hofstetter, Wayne L.; Ilson, David H.; Jalal, Shadia; Kim, Sunnie; Kleinberg, Lawrence R.; Klempner, Samuel; Lacy, Jill; Lee, Byrne; Licciardi, Frank; Lloyd, Shane; Ly, Quan P.; Matsukuma, Karen; McNamara, Michael; Merkow, Ryan P.; Miller, Aaron M.; Mukherjee, Sarbajit; Mulcahy, Mary F.; Perry, Kyle A.; Pimiento, Jose M.; Reddi, Deepti M.; Reznik, Scott; Roses, Robert E.; Strong, Vivian E.; Su, Stacey; Uboha, Nataliya; Wainberg, Zev A.; Willett, Christopher G.; Woo, Yanghee; Yoon, Harry H.; McMillian, Nicole R.; Stein, MaryElizabeth
Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials

Sacituzumab tirumotecan在有无EGFR突变晚期非小细胞肺癌中的研究：Ⅰ/Ⅱ期和Ⅱ期临床试验

NATURE MEDICINE
IF50
2025-04-100
PRE
Zhao, Shen; Cheng, Ying; Wang, Qiming; Li, Xingya; Liao, Jun; Rodon, Jordi; Meng, Xiangjiao; Luo, Yongzhong; Chen, Zhendong; Wang, Wei; Yi, Tienan; Li, Yongsheng; Yin, Yongmei; Xu, Huiting; Yu, Guohua; Mi, Yanjun; Fan, Yun; Wainberg, Zev A.; Wang, Xiang; Su, Cuiyun; Yu, Qitao; Lai, Shuzhen; Sun, Longhua; Zhuang, Wu; Wang, Xian; Yang, Jiacheng; Li, Yaling; Ge, Junyou; Li, Jin; Zhang, Li
S2303: phase II/III trial of paclitaxel plus ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)

S2303: 紫杉醇联合雷莫芦单抗 ± nivolumab治疗胃和食管腺癌 (PARAMUNE) 的II/III期试验

FUTURE ONCOLOGY
IF2.6
2025-03-010
OAAI
Saeed, Anwaar; Colby, Sarah; Oberstein, Paul Eliezer; Duda, Dan G.; Park, Robin; Agarwal, Rajiv; Figueroa-Moseley, Colmar; Vaidya, Riha; Unger, Joseph M.; Guthrie, Katherine A.; Rocha, Flavio G.; Senthil, Maheswari; Safyan, Rachael A.; Wainberg, Zev A.; Iqbal, Syma; Chiorean, E. Gabriela; Philip, Philip A.
Safety, PK, immune activation, and clinical outcomes with RBS2418 treatment, an oral ENPP1 inhibitor, alone or in combination with pembrolizumab in advanced solid tumors

安全性、PK（药代动力学）、免疫激活及临床结局：RBS2418（一种口服ENPP1抑制剂）单药或联合pembrolizumab治疗晚期实体瘤的疗效观察

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Marron, T.; Segar, J.; Berlin, J. D.; Boccia, R.; Spira, A. I.; Powderly, J.; Chen, C.; Wainberg, Z. A.; Schanzer, J. M.; Glenn, J.; Klumpp, K.; Csiki, I.; Misleh, J. G.
MK-2870-015: A phase III study of trophoblast antigen 2 (TROP2)-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) vs treatment of physician's choice (TPC) for previously treated metastatic gastroesophageal adenocarcinoma (GEA)

MK-2870-015：一项针对滋养层抗原2（TROP2）导向的抗体偶联药物（ADC）sacituzumab tirumotecan（sac-TMT）与研究者选择的治疗方案（TPC）用于既往治疗过的转移性胃食管腺癌（GEA）的III期研究

ANNALS OF ONCOLOGY
IF65.4
2024-09-011
PRE
Wainberg, Z. A.; Van Cutsem, E.; Shitara, K.; Janjigian, Y. Y.; Oh, D-Y.; Xu, J.; Wu, S.; Bhaumik, S.; Bhagia, P.; Tabernero, J.

研究方向

暂未获取到该数据
E
Eric Van Cutsem
H 指数:174论文数:1,832被引数:17.4万
E
Eileen M. O’Reilly
H 指数:100论文数:1,159被引数:4.3万
J
Josep Tabernero
H 指数:146论文数:2,711被引数:12.7万
T
Tanios Bekaii‐Saab
H 指数:82论文数:1,167被引数:2.7万
S
Shubham Pant
H 指数:48论文数:591被引数:1.0万
K
Kei Muro
H 指数:80论文数:1,040被引数:4.3万
K
Kohei Shitara
H 指数:79论文数:1,129被引数:3.5万
J
Johanna C. Bendell
H 指数:82论文数:928被引数:3.0万
F
Farshid Dayyani
H 指数:37论文数:296被引数:7,255
T
Teresa Macarulla
H 指数:63论文数:709被引数:2.1万